Interleukin-17A levels are also elevated in patients with AF (17), and treatment with anti-IL-17A monoclonal antibody markedly suppressed AF development in a rat model of sterile pericarditis, concomitantly reducing atrial inflammation and fibrosis (18). The gene discussed is IL17A; the disease is pericarditis.